JPM vs MDT Stock Comparison
MDT currently leads JPM in this stock comparison, with AIQ scores of 69 vs 53. The clearest difference is quality.
What is the main difference between JPM and MDT?
MDT leads the current stock comparison as Medtronic plc, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
JPMorgan Chase & Co. vs Medtronic plc
MDT leads
MDT leads by 16 AIQ points, primarily on Quality and Momentum, and the lead has widened from 12 points over 30 sessions. Wall Street currently favors JPM on target upside.
Stable: 4 of 6 evidence groups support MDT, its lead is widening, and its signal state is cleanly positive.
JPMorgan Chase & Co.
Medtronic plc
The Algovestiq AIQ Score currently favors MDT over JPM, 69 versus 53 as of Oct 31, 2026. MDT's advantage is driven primarily by stronger quality and momentum. MDT also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors JPM. 4 of 6 covered evidence groups favor MDT today, and the comparison is rated Stable on stability. MDT lead: Strengthening — the AIQ differential moved from 12 to 16 points over 30 sessions.
Compare JPMorgan Chase & Co. and Medtronic plc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare JPM and MDT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality46 vs 74MDT +28
- Momentum61 vs 77MDT +16
- Value44 vs 58MDT +14
- Risk Resilience69 vs 70Even
4 of 6 evidence groups favor MDT. MDT’s edge is concentrated in quality and momentum.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Momentum +2
New signals
- BB Upper Band Breach — bearish, volatility, short horizon
Largest factor move: Momentum -2
No signal started or stopped since the prior session; its 4 active signals are unchanged.
MDT's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — JPM and MDT both carry a full feed there.
The central trade-off
MDT (Medtronic plc): the stronger current systematic profile, led by quality and momentum.
JPM (JPMorgan Chase & Co.): the counter-case, on analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
MDTMDT on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
MDTMDT on combined revenue and EPS growth.
Value
MDTMDT on the peer-relative Value factor, by 14 points.
Momentum
MDTMDT on the Momentum factor, by 16 points.
Lower downside
JPMJPM carries the lower 1-month annualized volatility.
Analyst upside
JPMJPM on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors MDT, analyst targets favor JPM. That disagreement is the most useful thing on this page.
| Measure | JPM | MDT | Note |
|---|---|---|---|
| Implied upside to target | +10.7% | -1.3% | JPM has more room |
| Target dispersion | +32.2% | +36.7% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 15 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
Dividend growth
| Dividend metric | JPM | MDT |
|---|---|---|
| 5Y dividend CAGR | 9.04% | 4.42% |
| 2020 regular DPS | $3.600 | $2.280 |
| 2025 regular DPS | $5.550 | $2.830 |
| Years increased | 5 | 5 |
| No cut in window | Yes | Yes |
| Cohort rank | #120 | #271 |
JPM grew its split-adjusted regular dividend faster over 2020–2025 — 9.04% a year against MDT's 4.42%. Neither company reduced its regular dividend in any year of the window.
Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.
Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor MDT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | MDT | 53 vs 69 |
| Fundamentals | MDTon balance | revenue growth -7.6% vs 8.7%; EPS growth -27.6% vs 10.1%; TTM ROE 17.9% vs 14.2%; gross margin 63.2% vs 66.7%; operating margin 28.2% vs 18.1% — MDT takes 3 of 5 decided legs, not all of them |
| Valuation | MDT | Value 44 vs 58 |
| Technicals | MDT | Price vs 50-day -2% vs 5.4%; vs 200-day 5.2% vs 7.5% |
| Risk Resilience | Even | Risk Resilience 69 vs 70 |
| Analyst expectations | JPM | Target upside 10.7% vs -1.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of JPM and MDT and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 16 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on MDT.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28MDT lead: Strengthening — the AIQ differential moved from 12 to 16 points over 30 sessions.
- Today
- MDT +16
- 53 vs 69
- 7 sessions ago
- MDT +19
- 50 vs 69
- 30 sessions ago
- MDT +12
- 44 vs 56
- 90 sessions ago
- MDT +13
- 52 vs 65
The lead changed hands 2 times in this window, most recently on Jul 1 when MDT moved ahead of JPM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 1 bearish, conflicted
Only JPM
- BB Upper Band Breach — bearish, volatility, short horizon
4 bullish / 0 bearish
Only MDT
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: Golden Cross Active, MACD Bullish Crossover.
JPM is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.9%, AIQ +1 points).
Price and the AIQ Score both moved down over the latest session (price -0.59%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1JPM closes the Quality gap — currently 28 points behind, the largest single contributor to MDT's edge.
- 2JPM's BB Upper Band Breach resolves — a bearish volatility rule currently active against it.
- 3MDT's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
MDT leads on balance| Metric | JPM | MDT |
|---|---|---|
| Revenue growth (YoY) | -7.6% | 8.7% |
| EPS growth (YoY) | -27.6% | 10.1% |
| Gross margin | 63.2% | 66.7% |
| Operating margin | 28.2% | 18.1% |
| Return on equity (TTM) | 17.9% | 14.2% |
| Debt to equity | 3.32 | 0 |
Performance
MDT leads 4 of 6 windows| Metric | JPM | MDT |
|---|---|---|
| 1 week (5 sessions) | 1.2% | 1.9% |
| 1 month (20 sessions) | 2.6% | 9.8% |
| 3 months (63 sessions) | -3.3% | 10.6% |
| 6 months (126 sessions) | 9.7% | 15.3% |
| Year to date | 5.3% | -1.3% |
| 1 year (252 sessions) | 12.9% | 1.2% |
Technicals
MDT has the stronger structure| Metric | JPM | MDT |
|---|---|---|
| RSI (14) | 60.9 | 66.8 |
| ADX (14) | 15 | 20.6 |
| Price vs 50-day | -2% | 5.4% |
| Price vs 200-day | 5.2% | 7.5% |
| Volatility (1M, annualized) | 13% | 28.3% |
Risk
Split| Metric | JPM | MDT |
|---|---|---|
| Beta | 0.73 | 0.12 |
| Sharpe ratio | 0.41 | 0.03 |
| Sortino ratio | 0.56 | 0.05 |
| Max drawdown | -15.5% | -30% |
| Current drawdown | -7.1% | -10% |
| Annualized volatility | 22% | 24.7% |
| Value at risk (95%) | -2.4% | -2.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, JPM or MDT?
On the Algovestiq AIQ Score, MDT is the stronger of the two as of Oct 31, 2026, scoring 69 against JPM's 53. The edge comes from quality and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is JPM or MDT the better buy right now?
MDT carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor MDT over JPM?
The composite weights Quality, Value, Momentum and Risk Resilience. MDT leads Quality by 28 points; MDT leads Momentum by 16 points; MDT leads Value by 14 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, JPM or MDT?
Analyst price targets imply +10.7% upside for JPM and -1.3% for MDT, so the Street currently favors JPM. That points the opposite way to the AIQ Score, which favors MDT. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, JPM or MDT?
MDT is the better-valued of the two on the peer-relative Value factor. MDT on the peer-relative Value factor, by 14 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, JPM or MDT?
MDT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, JPM or MDT?
MDT on the Momentum factor, by 16 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, JPM or MDT?
JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is JPM more profitable than MDT?
The profitability evidence is mixed: gross margin 63.2% vs 66.7%; operating margin 28.2% vs 18.1%; ttm roe 17.9% vs 14.2%. JPM leads on two measures and MDT on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is MDT's lead over JPM getting stronger or weaker?
MDT lead: Strengthening — the AIQ differential moved from 12 to 16 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands 2 times in that window, most recently on 2026-07-01, when MDT moved ahead of JPM.
What would change the JPM vs MDT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Quality gap — currently 28 points behind, the largest single contributor to MDT's edge; JPM's BB Upper Band Breach resolves — a bearish volatility rule currently active against it; MDT's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about JPM and MDT?
JPM: 2 bullish / 1 bearish, conflicted. MDT: 4 bullish / 0 bearish. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on JPM is Golden Cross Active (bullish, long horizon). On MDT it is Golden Cross Active (bullish, long horizon).
Compare JPM and MDT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.